Recruiting studies: Hemophagocytic Lymphohistiocytoses

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07424222 Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06339177 Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Phase 2/Phase 3 · 41 location(s) · Electra Therapeutics Inc. · NCT05416307 Prospective Cohort for Adult Hemophagocytosis
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03117010 Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatm
Phase 1/Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT07525466 Prospective Single-Arm Clinical Trial of GO Regimen for HLH.
Phase 2/Phase 3 · 1 location(s) · Beijing Friendship Hospital · NCT07339345 Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT05898477 Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807 Prospective Validation of the OHI Index
Phase N/A · 2 location(s) · Meir Medical Center · NCT05882175 Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05762640 A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/
Phase 3 · 18 location(s) · TJ Biopharma Co., Ltd. · NCT07208058 INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05277272 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
Phase 4 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07270835 Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06585124 Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection
Phase N/A · 1 location(s) · Huazhong University of Science and Technology · NCT03491605 Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355 CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336 Assessing the Presence of CT-DNA in Lymphoma Associated HLH
Phase N/A · 1 location(s) · Nottingham University Hospitals NHS Trust · NCT05702502 Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
Phase 2 · 4 location(s) · Jerry Lee, MD, MSc, MPhil · NCT06160791 Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective St
Phase N/A · 1 location(s) · The Affiliated Hospital of Xuzhou Medical University · NCT06614998 Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
Phase 1 · 1 location(s) · Chinese PLA General Hospital · NCT06135922 A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH
NA · 1 location(s) · shifeng Lou · NCT05936086 Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-A
NA · 1 location(s) · Beijing Children's Hospital · NCT07488728 Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.